Achilles Therapeutics’ IPO nabs $175M to bring cell therapies to solid tumors March 31, 2021 Auto Bot BioPharma, biopharma nl, biotech IPO, cancer immunotherapy, Clinical Trials, London, Pharma 0 The Achilles Therapeutics IPO comes as several other biotechs make progress developing a type of cancer immunotherapy called a tumor-infiltrating lymphocyte. Clinical-stage Achilles contends its approach could best them all.